Pubblicazioni

The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature

2022 - FRONTIERS IN ONCOLOGY

Botticelli, A; Fabbri, A; Roberto, M; Alesini, D; Cirillo, A; D'Auria, G; Krasniqi, E; Marrucci, E; Muratore, M; Pantano, F; Pizzuti, L; Portarena, I; Rossi, R; Scagnoli, S; Marchetti, P.